BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 6, 2009
View Archived Issues
Data reported on two novel non-nucleoside HCV polymerase inhibitors -- VCH-222 and VCH-916
Read More
AT-406 shows synergistic antitumor activity with chemotherapy agents in vitro and in vivo
Read More
Memantine alleviates chronic pelvic pain symptoms in phase II trial; interim results presented
Read More
Adenoviral delivery of CD-40 ligand shows activity in patients with chronic lymphocytic leukemia
Read More
A recent Shionogi patent describes novel antibacterial agents
Read More
Takeda discloses new fatty acid amide hydrolase inhibitors
Read More
Xoma completes enrollment in phase I XOMA-052 program for type 2 diabetes
Read More
BD and Fujirebio sign biomarker assay agreement to improve cancer detection
Read More
Data confirms once-daily profile of LCP-Tacro extended-release tacrolimus
Read More
First quarter update from Chugai
Read More
Small stockpiles of an alternative drug may reduce resistance in influenza pandemic
Read More
E-10030 plus ranibizumab may cause regression of neovascular degeneration; phase I data disclosed
Read More
AL-8309A, a novel serotonin 5-HT1A agonist, presented as candidate for AMD therapy
Read More
Gabapentin enacarbil improves disease symptoms and sleep quality in restless legs syndrome
Read More
Ingenium claims novel CDK9 inhibitors that function as analgesics
Read More
Positive findings for QR-333 in diabetic peripheral neuropathy
Read More
Ghrelin receptor antagonists for the treatment of obesity described by AstraZeneca
Read More
Zoraxel improves erectile function in phase IIa study
Read More
CF-101 fails to meet endpoint in phase IIb rheumatoid arthritis study
Read More
Novel oncolytic compounds under early development at Merck KGaA
Read More
Bayer's low-dose contraceptive patch begins phase III
Read More
TZP-102 begins phase II study in diabetic patients with gastroparesis
Read More
AzaSite begins phase II program for blepharitis
Read More
AX-200 begins phase II efficacy trial for acute ischemic stroke
Read More
FDA grants orphan drug designation to Pervasis' Vascugel
Read More
Potentia reports results from phase I clinical trial of POT-4 in AMD
Read More
DMC recommends continuation of phase III SPEAR trial of Poniard's picoplatin in SCLC
Read More